Gene Therapeutic Approaches for Immune Modulation in AIDS

ISSN: 1875-614X (Online)
ISSN: 1871-5230 (Print)

Volume 15, 3 Issues, 2016

Download PDF Flyer

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Claudiu T. Supuran
Neurofarba Department
University of Florence

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Gene Therapeutic Approaches for Immune Modulation in AIDS

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 6(2): 121-140.

Author(s): Dorothee von Laer, Christopher Baum, Axel Schambach, Klaus Kuhlcke, Roland Zahn, Sebastian Newrzela, Jan van Lunzen, R. Paul Johnson and Jorn E Schmitz.

Affiliation: Georg-Speyer-Haus, Paul-Ehrlich-Strasse 42-44, 60596 Frankfurt A.M. Germany.


Antiviral drug therapy can effectively suppress HIV replication, but emerging viral resistance and drug toxicity limit long-term therapeutic efficacy. In addition, regeneration of the T helper cell repertoire is often incomplete. The current major challenges in the treatment of HIV infection are therefore the reconstitution of cellular immunity, and especially of the HIV-specific immune response, and the suppression of virus replication in patients with HAART failure. Several gene therapeutic strategies for immune reconstitution of AIDS patients have been described. Preclinical and clinical studies have examined the safety and efficacy of two basic approaches: firstly, the transfer of autologous T cells armed with recombinant receptors that target HIV antigens to specifically increase antiviral immunity and, secondly, the transfer of genetically modified T cells or hematopoietic progenitor cells that express an antiviral gene. However, for both approaches, engraftment levels of gene-modified cells have not been sufficient to reconstitute cellular immunity and to effectively reduce the overall viral load in patients. Strategies to improve the technologies and procedures involved in gene therapeutic immune reconstitution of AIDS patients are discussed.


HIV infection, stem cell transplantation, T cell therapy, immune reconstitution.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 6
Issue Number: 2
First Page: 121
Last Page: 140
Page Count: 20
DOI: 10.2174/187152307780598081
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science